Menu
Your Cart

Apostle MiniGenomics High Efficiency Urinary Tract Microbiota DNA Isolation Kit (400uL x 50 preps)

Apostle MiniGenomics High Efficiency Urinary Tract Microbiota DNA Isolation Kit (400uL x 50 preps)
Secured Shopping
Best security features
Apostle MiniGenomics High Efficiency Urinary Tract Microbiota DNA Isolation Kit (400uL x 50 preps)
  • The Apostle MiniGenomics High Efficiency Urinary Tract Microbiota DNA Isolation Kit is designed for isolation of microbial DNA from urine samples. The kit uses proprietary Apostle MiniGenomics technology, offers highly efficient, reproducible recovery of high-quality bacterial DNA with high yield. The isolated DNA samples are suitable for a broad range of subsequent applications, including sequencing, PCR, etc.
  • The protocol is designed for 96-well plate automated on Apostle MagTouch 2000 Automation Platform. Especially for samples with extreme low dilute bacteria concentration, centrifugal and concentration pretreatment could increase the total microbial DNA product.
  • For urine samples with broad range of bacteria concertration (from 10^6 to10^1 cfu/mL), Apostle MiniGenomics High Efficiency Urinary Tract Microbiota DNA Isolation Kit isolates microbial DNA with steady recovery and high efficiency, and no significant PCR inhibitors remain in the DNA product. 
  • Configuration: 400uL x 50 preps (A210701-50).   
  • Cat #: A210701-50


Documentation


Protocol: https://www.apostlebio.com/minimax/MagTouch2000_96wells_400μL_Urine_Extraction_Protocol_1.4.pdf



$359.50
A new clinical study, led by scientists from MD Anderson Cancer Center and published in Cancer Cell (journal impact factor = 50.3), shows that tumor and cfDNA methylation can be used to identify SCLC subtypes and might guide precision SCLC therapy. Apostle MiniMax cfDNA kit is one of the critical commercial assays listed in this article. Congratulations to this clinical research team. To date, the Apostle MiniMax technology has been used in 2 articles published in Nature Communications, 2 in Nature Medicine, 1 in Science Translational Medicine, 1 in PNAS, and over 60 scientific articles by over 60 international research and clinical teams in different journals.